South Koreans are on high alert for Chinese money in the local entertainment industry after the SBS historical drama “Joseon Exorcist” was canceled last month due to cultural appropriation by China and Chinese product placements.
Chinese foods, such as moon cakes and Chinese-style dumplings, and Chinese-style sets and props were used in “Joseon Exorcist”, which was set in Korea’s Joseon Kingdom.
Although the drama was entirely bankrolled by Koreans, the scenes represent growing cultural appropriation by China.
According to a production company marketing official, the production cost per episode is now around 600 million to 700 million won, which is difficult to cover the costs with just local advertisements.
The Chinese are investing in Korean dramas to help its streaming services to expand into countries where K-dramas are popular and to promote their products globally through product placements.
Hoping to replicate that success, Chinese platform iQiyi bought the foreign streaming rights to “Cliffhanger," and numerous Korean dramas.
Last year, Tencent invested 100 billion won in JTBC Studio, which made “The World of the Married” and “Itaewon Class.”'
Earlier this year, tvN’s webtoon-based drama “True Beauty” was criticized for scenes where Korean high school students were eating instant hotpot from Chinese company Zihaiguo, saying the blatant product placement interfered with the viewing experience.
South Koreans also urged a boycott of companies, actors, and staff that invested in the production of “Joseon Exorcist,” labeling them as ignorant of history.


U.S. Dollar Slips as Yen Finds Support on Intervention Signals and Geopolitical Risks Rise
Japan Plans $189 Billion Bond Issuance as Record Budget Signals Expansionary Fiscal Policy
U.S. Stocks Rally to Record Highs as AI Rebound Fuels Holiday-Shortened Session
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
China Keeps Benchmark Lending Rates Steady as Economic Outlook Remains Cautious
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Asian Stocks Rise as Wall Street Tech Rally Lifts Markets, Yen Slumps Despite BOJ Rate Hike
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
UK Economy Grows 0.1% in Q3 2025 as Outlook Remains Fragile
FDA Approves Mitapivat for Anemia in Thalassemia Patients
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 



